• United Kingdom

U.K. Biotech Stocks Analysis

AIM:DEST
AIM:DEST
AIM:DESTBiotechs

For Destiny Pharma plc (LON:DEST) insiders, selling UK£420k worth of stock earlier this year was a smart move.

May 17, 2022
Last week, Destiny Pharma plc's (LON:DEST) stock jumped 15%, but insiders who sold UK£420k worth of stock in over the...
AIM:CIR
AIM:CIR
AIM:CIRBiotechs

Circassia Group (LON:CIR) adds UK£20m to market cap in the past 7 days, though investors from five years ago are still down 63%

May 17, 2022
This week we saw the Circassia Group Plc ( LON:CIR ) share price climb by 15%. But that doesn't change the fact that...
LSE:GNS
LSE:GNS
LSE:GNSBiotechs

Does The Market Have A Low Tolerance For Genus plc's (LON:GNS) Mixed Fundamentals?

May 14, 2022
Genus (LON:GNS) has had a rough three months with its share price down 27%. We, however decided to study the company's...
LSE:OXB
LSE:OXB
LSE:OXBBiotechs

Investors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust Earnings

May 02, 2022
Oxford Biomedica plc's ( LON:OXB ) robust earnings report didn't manage to move the market for its stock. Our analysis...
AIM:ABC
AIM:ABC
AIM:ABCBiotechs

Is Abcam (LON:ABC) A Risky Investment?

May 01, 2022
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
LSE:PRTC
LSE:PRTC
LSE:PRTCBiotechs

Is PureTech Health (LON:PRTC) A Risky Investment?

April 28, 2022
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
AIM:AVCT
AIM:AVCT
AIM:AVCTBiotechs

The 12% return this week takes Avacta Group's (LON:AVCT) shareholders three-year gains to 338%

April 25, 2022
For us, stock picking is in large part the hunt for the truly magnificent stocks. Not every pick can be a winner, but...
AIM:ETX
AIM:ETX
AIM:ETXBiotechs

Insiders who purchased e-therapeutics plc (LON:ETX) earlier this year lose an additional UK£35k as the stock sinks to UK£0.24

April 25, 2022
The recent price decline of 11% in e-therapeutics plc's ( LON:ETX ) stock may have disappointed insiders who bought...
LSE:OXB
LSE:OXB
LSE:OXBBiotechs

Oxford Biomedica plc (LON:OXB) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

April 22, 2022
With its stock down 38% over the past three months, it is easy to disregard Oxford Biomedica (LON:OXB). However, stock...
  • 1
  • 2
  • 3
  • 4
  • 5
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Company
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.